NASDAQ
1.71USD
-0.06 (-3.39%)
We have scored 4 news catalysts on Intelligent Bio Solutions Inc. (INBS) over the past 12 months. The biggest single-day move next to one of them came Dec 31, 2025, when INBS closed +132.4%: “Intelligent Bio Stock Doubles On New Manufacturing Deal Promising Major Cost Cuts”. Coverage across the window leans positive (average ticker sentiment +0.40). Most of the impact sits in price momentum and short squeeze potential.
Dots are scored news catalysts — size = impact, color = sentiment. Tap one to read it.
Market cap
1.1M
P/E
—
EPS
—
Beta
4.25
52W range
1.52-24.9
Day range
1.66–1.84
Open
1.79
Prev close
1.77
Volume
93.8K
Avg volume
136.4K
Dividend
0.00
IPO
2020-12-23
Daily OHLCV with SMA overlays and session pivots. Draw your levels and trendlines on it, or ask the AI analyst what the price is reacting to.
Suppliers, customers, partners and competitors, derived from what the news actually says about Intelligent Bio Solutions Inc. — not a sector bucket. Click an edge to see the articles that established the link.
Latest scored catalyst for INBS: .
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Intelligent Bio Solutions Inc. operates as a life sciences firm focused on developing non-invasive, real-time monitoring and diagnostic solutions for both patients and their primary healthcare providers. A notable product in its portfolio is the Saliva Glucose Biosensor, an organic thin-film transistor designed to precisely measure glucose levels in saliva for effective diabetes management. Beyond this, the company is actively developing a SARS-CoV-2 Biosensor, intended to serve as a supplementary diagnostic tool to existing RNA virus detection methods. It also maintains a broad biosensor platform that encompasses diverse diagnostic modalities, including biochemistry, immunology, tumor marker identification, hormone analysis, and nucleic acid diagnostics. Incorporated in 2016 and based in New York, New York, the company was formerly known as GBS Inc. before adopting its current name in October 2022. Intelligent Bio Solutions Inc. operates as a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.
